413 related articles for article (PubMed ID: 32290429)
1. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.
Glorieux G; Gryp T; Perna A
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429
[TBL] [Abstract][Full Text] [Related]
2. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
3. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.
Vaziri ND
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):587-92. PubMed ID: 23010760
[TBL] [Abstract][Full Text] [Related]
4. Gut-Derived Protein-Bound Uremic Toxins.
Graboski AL; Redinbo MR
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
[TBL] [Abstract][Full Text] [Related]
5. Thrombolome and Its Emerging Role in Chronic Kidney Diseases.
Fryc J; Naumnik B
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803899
[TBL] [Abstract][Full Text] [Related]
6. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
Briskey D; Tucker P; Johnson DW; Coombes JS
Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
[TBL] [Abstract][Full Text] [Related]
7. Microbiota issue in CKD: how promising are gut-targeted approaches?
Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
Filipska I; Winiarska A; Knysak M; Stompór T
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
[TBL] [Abstract][Full Text] [Related]
10. Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?
Dai L; Meijers BK; Bammens B; de Loor H; Schurgers LJ; Qureshi AR; Stenvinkel P; Evenepoel P
Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32471179
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
12. The gut-kidney axis.
Evenepoel P; Poesen R; Meijers B
Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease and the gut microbiome.
Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
[TBL] [Abstract][Full Text] [Related]
14. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
15. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
[TBL] [Abstract][Full Text] [Related]
16. From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.
Vitetta L; Linnane AW; Gobe GC
Toxins (Basel); 2013 Nov; 5(11):2042-57. PubMed ID: 24212182
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis.
Chaves LD; McSkimming DI; Bryniarski MA; Honan AM; Abyad S; Thomas SA; Wells S; Buck M; Sun Y; Genco RJ; Quigg RJ; Yacoub R
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F487-F502. PubMed ID: 29693447
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease.
Steenbeke M; Valkenburg S; Gryp T; Van Biesen W; Delanghe JR; Speeckaert MM; Glorieux G
Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822593
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome in chronic kidney disease: challenges and opportunities.
Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
[TBL] [Abstract][Full Text] [Related]
20. [Uremic toxins and gut micro biome].
Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
